Therapeutic targeting of aldose reductase is therefore proposed as a noble strategy for treating diabetes mellitus (Suzen and Buyukbingol, 2003; Maccari and Ottanà, 2015). The gene discussed is AKR1B1; the disease is diabetes mellitus.